Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. [electronic resource]
Producer: 19980820Description: 8880-5 p. digitalISSN:- 0027-8424
- Animals
- Anticholesteremic Agents -- pharmacology
- Cells, Cultured
- Diterpenes -- antagonists & inhibitors
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Ischemic Attack, Transient -- pathology
- Lovastatin -- pharmacology
- Mice
- Mice, Inbred C57BL
- Nitric Oxide Synthase -- metabolism
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Simvastatin -- pharmacology
- Tumor Cells, Cultured
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.